{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:51:06Z","timestamp":1790157066632,"version":"4.0.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["653706"],"award-info":[{"award-number":["653706"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004504","name":"Lietuvos Mokslo Taryba","doi-asserted-by":"publisher","award":["S-MIP-17-87"],"award-info":[{"award-number":["S-MIP-17-87"]}],"id":[{"id":"10.13039\/501100004504","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Secretory human carbonic anhydrase VI (CA VI) has emerged as a potential drug target due to its role in pathological states, such as excess acidity-caused dental caries and injuries of gastric epithelium. Currently, there are no available CA VI-selective inhibitors or crystallographic structures of inhibitors bound to CA VI. The present study focuses on the site-directed CA II mutant mimicking the active site of CA VI for inhibitor screening. The interactions between CA VI-mimic and a series of benzenesulfonamides were evaluated by fluorescent thermal shift assay, stopped-flow CO\n                    <jats:sub>2<\/jats:sub>\n                    hydration assay, isothermal titration calorimetry, and X-ray crystallography. Kinetic parameters showed that A65T, N67Q, F130Y, V134Q, L203T mutations did not influence catalytic properties of CA II, but inhibitor affinities resembled CA VI, exhibiting up to 0.16\u2009nM intrinsic affinity for CA VI-mimic. Structurally, binding site of CA VI-mimic was found to be similar to CA VI. The ligand interactions with mutated side chains observed in three crystallographic structures allowed to rationalize observed variation of binding modes and experimental binding affinities to CA VI. This integrative set of kinetic, thermodynamic, and structural data revealed CA VI-mimic as a useful model to design CA VI-specific inhibitors which could be beneficial for novel therapeutic applications.\n                  <\/jats:p>","DOI":"10.1038\/s41598-019-49094-0","type":"journal-article","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T06:08:04Z","timestamp":1567490884000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Engineered Carbonic Anhydrase VI-Mimic Enzyme Switched the Structure and Affinities of Inhibitors"],"prefix":"10.1038","volume":"9","author":[{"given":"Justina","family":"Kazokait\u0117","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Visvaldas","family":"Kairys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Smirnovien\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey","family":"Smirnov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Manakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martti","family":"Tolvanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seppo","family":"Parkkila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6178-6276","authenticated-orcid":false,"given":"Daumantas","family":"Matulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,3]]},"reference":[{"key":"49094_CR1","first-page":"15","volume":"75","author":"N Meldrum","year":"1932","unstructured":"Meldrum, N. & Roughton, F. Some properties of carbonic anhydrase, the CO2 enzyme present in blood. J Physiol 75, 15\u20136 (1932).","journal-title":"J Physiol"},{"key":"49094_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-94-007-7359-2_2","volume":"75","author":"SC Frost","year":"2014","unstructured":"Frost, S. C. Physiological functions of the alpha class of carbonic anhydrases. Subcell. Biochem. 75, 9\u201330 (2014).","journal-title":"Subcell. Biochem."},{"key":"49094_CR3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3109\/14756366.2012.737323","volume":"28","author":"M Aggarwal","year":"2013","unstructured":"Aggarwal, M., Boone, C. D., Kondeti, B. & McKenna, R. Structural annotation of human carbonic anhydrases. J Enzyme Inhib Med Chem 28, 267\u2013277 (2013).","journal-title":"J Enzyme Inhib Med Chem"},{"key":"49094_CR4","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1016\/j.bmcl.2005.06.054","volume":"15","author":"F Mincione","year":"2005","unstructured":"Mincione, F. et al. Carbonic anhydrase inhibitors: design of thioureido sulfonamides with potent isozyme II and XII inhibitory properties and intraocular pressure lowering activity in a rabbit model of glaucoma. Bioorg. Med. Chem. Lett. 15, 3821\u20133827 (2005).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"49094_CR5","doi-asserted-by":"publisher","first-page":"855","DOI":"10.2174\/156802607780636726","volume":"7","author":"A Thiry","year":"2007","unstructured":"Thiry, A., Dogn\u00e9, J.-M., Supuran, C. T. & Masereel, B. Carbonic anhydrase inhibitors as anticonvulsant agents. Curr Top Med Chem 7, 855\u2013864 (2007).","journal-title":"Curr Top Med Chem"},{"key":"49094_CR6","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1517\/13543776.2013.790957","volume":"23","author":"A Scozzafava","year":"2013","unstructured":"Scozzafava, A., Supuran, C. T. & Carta, F. Antiobesity carbonic anhydrase inhibitors: a literature and patent review. Expert Opinion on Therapeutic Patents 23, 725\u2013735 (2013).","journal-title":"Expert Opinion on Therapeutic Patents"},{"key":"49094_CR7","doi-asserted-by":"crossref","unstructured":"Mboge, M. Y., Mahon, B. P., McKenna, R. & Frost, S. C. Carbonic Anhydrases: Role in pH Control and Cancer. Metabolites 8 (2018).","DOI":"10.3390\/metabo8010019"},{"key":"49094_CR8","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1021\/cr200176r","volume":"112","author":"V Alterio","year":"2012","unstructured":"Alterio, V., Di Fiore, A., D\u2019Ambrosio, K., Supuran, C. T. & De Simone, G. Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms? Chem. Rev. 112, 4421\u20134468 (2012).","journal-title":"Chem. Rev."},{"key":"49094_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/453543","volume":"2015","author":"Melissa A. Pinard","year":"2015","unstructured":"Pinard, M. A. et al. Probing the Surface of Human Carbonic Anhydrase for Clues towards the Design of Isoform Specific Inhibitors, Probing the Surface of Human Carbonic Anhydrase for Clues towards the Design of Isoform Specific Inhibitors. BioMed Research International, BioMed Research International 2015, 2015, e453543 (2015).","journal-title":"BioMed Research International"},{"key":"49094_CR10","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0021-9258(19)75797-4","volume":"262","author":"H Murakami","year":"1987","unstructured":"Murakami, H. & Sly, W. S. Purification and characterization of human salivary carbonic anhydrase. J. Biol. Chem. 262, 1382\u20131388 (1987).","journal-title":"J. Biol. Chem."},{"key":"49094_CR11","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1093\/clinchem\/43.12.2318","volume":"43","author":"J Kivel\u00e4","year":"1997","unstructured":"Kivel\u00e4, J. et al. Secretory carbonic anhydrase isoenzyme (CA VI) in human serum. Clin. Chem. 43, 2318\u20132322 (1997).","journal-title":"Clin. Chem."},{"key":"49094_CR12","doi-asserted-by":"publisher","first-page":"11604","DOI":"10.1073\/pnas.121172598","volume":"98","author":"P Karhumaa","year":"2001","unstructured":"Karhumaa, P. et al. The identification of secreted carbonic anhydrase VI as a constitutive glycoprotein of human and rat milk. Proc Natl Acad Sci USA 98, 11604\u201311608 (2001).","journal-title":"Proc Natl Acad Sci USA"},{"key":"49094_CR13","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1369\/jhc.4A6282.2004","volume":"52","author":"JS Leinonen","year":"2004","unstructured":"Leinonen, J. S., Saari, K. A., Sepp\u00e4nen, J. M., Myllyl\u00e4, H. M. & Rajaniemi, H. J. Immunohistochemical demonstration of carbonic anhydrase isoenzyme VI (CA VI) expression in rat lower airways and lung. J. Histochem. Cytochem. 52, 1107\u20131112 (2004).","journal-title":"J. Histochem. Cytochem."},{"key":"49094_CR14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1292\/jvms.68.131","volume":"68","author":"M Kaseda","year":"2006","unstructured":"Kaseda, M., Ichihara, N., Nishita, T., Amasaki, H. & Asari, M. Immunohistochemistry of the bovine secretory carbonic anhydrase isozyme (CA-VI) in bovine alimentary canal and major salivary glands. J. Vet. Med. Sci. 68, 131\u2013135 (2006).","journal-title":"J. Vet. Med. Sci."},{"key":"49094_CR15","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s11248-010-9441-2","volume":"20","author":"P Pan","year":"2011","unstructured":"Pan, P. et al. Gene expression profiling in the submandibular gland, stomach, and duodenum of CAVI-deficient mice. Transgenic Res. 20, 675\u2013698 (2011).","journal-title":"Transgenic Res."},{"key":"49094_CR16","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s11248-016-9961-5","volume":"25","author":"MS Patrikainen","year":"2016","unstructured":"Patrikainen, M. S., Pan, P., Barker, H. R. & Parkkila, S. Altered gene expression in the lower respiratory tract of Car6 (\u2212\/\u2212) mice. Transgenic Res. 25, 649\u2013664 (2016).","journal-title":"Transgenic Res."},{"key":"49094_CR17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12929-014-0082-2","volume":"21","author":"M Patrikainen","year":"2014","unstructured":"Patrikainen, M., Pan, P., Kulesskaya, N., Voikar, V. & Parkkila, S. The role of carbonic anhydrase VI in bitter taste perception: evidence from the Car6\u2212\/\u2212 mouse model. J Biomed Sci 21, 82 (2014).","journal-title":"J Biomed Sci"},{"key":"49094_CR18","doi-asserted-by":"publisher","first-page":"e74151","DOI":"10.1371\/journal.pone.0074151","volume":"8","author":"M Melis","year":"2013","unstructured":"Melis, M. et al. The gustin (CA6) gene polymorphism, rs2274333 (A\/G), as a mechanistic link between PROP tasting and fungiform taste papilla density and maintenance. PLoS One 8, e74151 (2013).","journal-title":"PLoS One"},{"issue":"Pt 2","key":"49094_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1469-7793.1999.t01-1-00315.x","volume":"520","author":"J Kivela","year":"1999","unstructured":"Kivela, J., Parkkila, S., Parkkila, A. K., Leinonen, J. & Rajaniemi, H. Salivary carbonic anhydrase isoenzyme VI. J. Physiol. (Lond.) 520(Pt 2), 315\u2013320 (1999).","journal-title":"J. Physiol. (Lond.)"},{"key":"49094_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.archoralbio.2005.04.007","volume":"51","author":"M Kimoto","year":"2006","unstructured":"Kimoto, M., Kishino, M., Yura, Y. & Ogawa, Y. A role of salivary carbonic anhydrase VI in dental plaque. Arch. Oral Biol. 51, 117\u2013122 (2006).","journal-title":"Arch. Oral Biol."},{"key":"49094_CR21","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1023\/A:1018889120034","volume":"42","author":"S Parkkila","year":"1997","unstructured":"Parkkila, S. et al. Salivary carbonic anhydrase protects gastroesophageal mucosa from acid injury. Dig. Dis. Sci. 42, 1013\u20131019 (1997).","journal-title":"Dig. Dis. Sci."},{"key":"49094_CR22","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1016\/j.bmc.2012.04.044","volume":"21","author":"MI Hassan","year":"2013","unstructured":"Hassan, M. I., Shajee, B., Waheed, A., Ahmad, F. & Sly, W. S. Structure, function and applications of carbonic anhydrase isozymes. Bioorg Med Chem 21, 1570\u20131582 (2013).","journal-title":"Bioorg Med Chem"},{"key":"49094_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.semcancer.2014.08.002","volume":"31","author":"J Pastorek","year":"2015","unstructured":"Pastorek, J. & Pastorekova, S. Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: From biology to clinical use. Seminars in Cancer Biology 31, 52\u201364 (2015).","journal-title":"Seminars in Cancer Biology"},{"key":"49094_CR24","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1016\/S0021-9258(18)48696-6","volume":"238","author":"BH Gibbons","year":"1963","unstructured":"Gibbons, B. H. & Edsall, J. T. Rate of Hydration of Carbon Dioxide and Dehydration of Carbonic Acid At 25 Degrees. J. Biol. Chem. 238, 3502\u20133507 (1963).","journal-title":"J. Biol. Chem."},{"key":"49094_CR25","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","volume":"246","author":"RG Khalifah","year":"1971","unstructured":"Khalifah, R. G. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J. Biol. Chem. 246, 2561\u20132573 (1971).","journal-title":"J. Biol. Chem."},{"key":"49094_CR26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ab.2017.01.022","volume":"522","author":"J Smirnovien\u0117","year":"2017","unstructured":"Smirnovien\u0117, J., Smirnovas, V. & Matulis, D. Picomolar inhibitors of carbonic anhydrase: Importance of inhibition and binding assays. Anal. Biochem. 522, 61\u201372 (2017).","journal-title":"Anal. Biochem."},{"key":"49094_CR27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/B978-0-12-381274-2.00011-X","volume":"493","author":"JK Kranz","year":"2011","unstructured":"Kranz, J. K. & Schalk-Hihi, C. Protein thermal shifts to identify low molecular weight fragments. Meth. Enzymol. 493, 277\u2013298 (2011).","journal-title":"Meth. Enzymol."},{"key":"49094_CR28","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1038\/nprot.2007.321","volume":"2","author":"FH Niesen","year":"2007","unstructured":"Niesen, F. H., Berglund, H. & Vedadi, M. The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability. Nat Protoc 2, 2212\u20132221 (2007).","journal-title":"Nat Protoc"},{"key":"49094_CR29","doi-asserted-by":"publisher","first-page":"5258","DOI":"10.1021\/bi048135v","volume":"44","author":"D Matulis","year":"2005","unstructured":"Matulis, D., Kranz, J. K., Salemme, F. R. & Todd, M. J. Thermodynamic stability of carbonic anhydrase: measurements of binding affinity and stoichiometry using ThermoFluor. Biochemistry 44, 5258\u20135266 (2005).","journal-title":"Biochemistry"},{"key":"49094_CR30","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/jmr.2330","volume":"27","author":"T Rogez-Florent","year":"2014","unstructured":"Rogez-Florent, T. et al. Label-free characterization of carbonic anhydrase-novel inhibitor interactions using surface plasmon resonance, isothermal titration calorimetry and fluorescence-based thermal shift assays. J. Mol. Recognit. 27, 46\u201356 (2014).","journal-title":"J. Mol. Recognit."},{"key":"49094_CR31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1517\/17460441.2012.666235","volume":"7","author":"NC Garbett","year":"2012","unstructured":"Garbett, N. C. & Chaires, J. B. Thermodynamic studies for drug design and screening. Expert Opin Drug Discov 7, 299\u2013314 (2012).","journal-title":"Expert Opin Drug Discov"},{"key":"49094_CR32","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/cmdc.201600509","volume":"12","author":"A Zubrien\u0117","year":"2017","unstructured":"Zubrien\u0117, A. et al. Intrinsic Thermodynamics and Structures of 2,4- and 3,4-Substituted Fluorinated Benzenesulfonamides Binding to Carbonic Anhydrases. ChemMedChem 12, 161\u2013176 (2017).","journal-title":"ChemMedChem"},{"key":"49094_CR33","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.bbagen.2016.01.007","volume":"1860","author":"V Linkuvien\u0117","year":"2016","unstructured":"Linkuvien\u0117, V. et al. Intrinsic thermodynamics of inhibitor binding to human carbonic anhydrase IX. Biochimica et Biophysica Acta (BBA) - General Subjects 1860, 708\u2013718 (2016).","journal-title":"Biochimica et Biophysica Acta (BBA) - General Subjects"},{"key":"49094_CR34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bpc.2015.05.009","volume":"205","author":"A Zubrien\u0117","year":"2015","unstructured":"Zubrien\u0117, A. et al. Intrinsic thermodynamics of 4-substituted-2,3,5,6-tetrafluorobenzenesulfonamide binding to carbonic anhydrases by isothermal titration calorimetry. Biophys. Chem. 205, 51\u201365 (2015).","journal-title":"Biophys. Chem."},{"key":"49094_CR35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/2046-1682-5-12","volume":"5","author":"L Baranauskien\u0117","year":"2012","unstructured":"Baranauskien\u0117, L. & Matulis, D. Intrinsic thermodynamics of ethoxzolamide inhibitor binding to human carbonic anhydrase XIII. BMC Biophys 5, 12 (2012).","journal-title":"BMC Biophys"},{"key":"49094_CR36","doi-asserted-by":"crossref","unstructured":"Rosano, G. L. & Ceccarelli, E. A. Recombinant protein expression in Escherichia coli: advances and challenges. Front Microbiol 5 (2014).","DOI":"10.3389\/fmicb.2014.00172"},{"key":"49094_CR37","doi-asserted-by":"crossref","unstructured":"Jia, B. & Jeon, C. O. High-throughput recombinant protein expression in Escherichia coli: current status and future perspectives. Open Biol 6 (2016).","DOI":"10.1098\/rsob.160196"},{"key":"49094_CR38","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10930-013-9502-5","volume":"32","author":"GJ Gopal","year":"2013","unstructured":"Gopal, G. J. & Kumar, A. Strategies for the production of recombinant protein in Escherichia coli. Protein J. 32, 419\u2013425 (2013).","journal-title":"Protein J."},{"key":"49094_CR39","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1110\/ps.041009005","volume":"14","author":"S Idicula-Thomas","year":"2005","unstructured":"Idicula-Thomas, S. & Balaji, P. V. Understanding the relationship between the primary structure of proteins and its propensity to be soluble on overexpression in Escherichia coli. Protein Sci. 14, 582\u2013592 (2005).","journal-title":"Protein Sci."},{"key":"49094_CR40","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1111\/febs.13196","volume":"282","author":"J Kazokait\u0117","year":"2015","unstructured":"Kazokait\u0117, J., Milinavi\u010di\u016bt\u0117, G., Smirnovien\u0117, J., Matulien\u0117, J. & Matulis, D. Intrinsic binding of 4-substituted-2,3,5,6-tetrafluorobenezenesulfonamides to native and recombinant human carbonic anhydrase VI. FEBS J. 282, 972\u2013983 (2015).","journal-title":"FEBS J."},{"key":"49094_CR41","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3109\/14756366.2014.908291","volume":"30","author":"V Mork\u016bnait\u0117","year":"2015","unstructured":"Mork\u016bnait\u0117, V. et al. Intrinsic thermodynamics of sulfonamide inhibitor binding to human carbonic anhydrases I and II. J Enzyme Inhib Med Chem 30, 204\u2013211 (2015).","journal-title":"J Enzyme Inhib Med Chem"},{"key":"49094_CR42","doi-asserted-by":"crossref","unstructured":"Cimmperman, P. & Matulis, D. Chapter 8:Protein Thermal Denaturation Measurements via a Fluorescent Dye. In Chapter 8:Protein Thermal Denaturation Measurements via a Fluorescent Dye 247\u2013274 (2011).","DOI":"10.1039\/9781849732666-00247"},{"key":"49094_CR43","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrd.2017.219","volume":"17","author":"GA Holdgate","year":"2018","unstructured":"Holdgate, G. A., Meek, T. D. & Grimley, R. L. Mechanistic enzymology in drug discovery: a fresh perspective. Nature Reviews Drug Discovery 17, 115\u2013132 (2018).","journal-title":"Nature Reviews Drug Discovery"},{"key":"49094_CR44","doi-asserted-by":"publisher","first-page":"5351","DOI":"10.1016\/j.bmc.2007.03.004","volume":"15","author":"I Nishimori","year":"2007","unstructured":"Nishimori, I. et al. Carbonic anhydrase activators: the first activation study of the human secretory isoform VI with amino acids and amines. Bioorg. Med. Chem. 15, 5351\u20135357 (2007).","journal-title":"Bioorg. Med. Chem."},{"key":"49094_CR45","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/j.1747-0285.2009.00902.x","volume":"74","author":"J-Y Winum","year":"2009","unstructured":"Winum, J.-Y., Montero, J.-L., Vullo, D. & Supuran, C. T. Carbonic anhydrase inhibitors: glycosylsulfanilamides act as subnanomolar inhibitors of the human secreted isoform VI. Chem Biol Drug Des 74, 636\u2013639 (2009).","journal-title":"Chem Biol Drug Des"},{"key":"49094_CR46","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1021\/jm301625s","volume":"56","author":"K Tars","year":"2013","unstructured":"Tars, K. et al. Sulfocoumarins (1,2-Benzoxathiine-2,2-dioxides): A Class of Potent and Isoform-Selective Inhibitors of Tumor-Associated Carbonic Anhydrases. J. Med. Chem. 56, 293\u2013300 (2013).","journal-title":"J. Med. Chem."},{"key":"49094_CR47","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1021\/bi802035f","volume":"48","author":"C Genis","year":"2009","unstructured":"Genis, C. et al. Design of a carbonic anhydrase IX active-site mimic to screen inhibitors for possible anticancer properties. Biochemistry 48, 1322\u20131331 (2009).","journal-title":"Biochemistry"},{"key":"49094_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/157018011796576105","volume":"8","author":"KH Sippel","year":"2011","unstructured":"Sippel, K. H. et al. Characterization of Carbonic Anhydrase Isozyme Specific Inhibition by Sulfamated 2-Ethylestra Compounds. Lett. Drug Des. Discovery 8, 1\u201325 (2011).","journal-title":"Lett. Drug Des. Discovery"},{"key":"49094_CR49","doi-asserted-by":"publisher","first-page":"8635","DOI":"10.1021\/jm5012935","volume":"57","author":"J Moeker","year":"2014","unstructured":"Moeker, J. et al. Structural Insights into Carbonic Anhydrase IX Isoform Specificity of Carbohydrate-Based Sulfamates. Journal of Medicinal Chemistry 57, 8635\u20138645 (2014).","journal-title":"Journal of Medicinal Chemistry"},{"key":"49094_CR50","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1107\/S2053230X1501239X","volume":"71","author":"MA Pinard","year":"2015","unstructured":"Pinard, M. A., Aggarwal, M., Mahon, B. P., Tu, C. & McKenna, R. A sucrose-binding site provides a lead towards an isoform-specific inhibitor of the cancer-associated enzyme carbonic anhydrase IX. Acta Crystallogr F Struct Biol Commun 71, 1352\u20131358 (2015).","journal-title":"Acta Crystallogr F Struct Biol Commun"},{"key":"49094_CR51","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.bmc.2014.12.030","volume":"23","author":"BP Mahon","year":"2015","unstructured":"Mahon, B. P. et al. Saccharin: A lead compound for structure-based drug design of carbonic anhydrase IX inhibitors. Bioorganic & Medicinal Chemistry 23, 849\u2013854 (2015).","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"49094_CR52","doi-asserted-by":"publisher","first-page":"7210","DOI":"10.1016\/j.bmc.2013.08.033","volume":"21","author":"MA Pinard","year":"2013","unstructured":"Pinard, M. A., Boone, C. D., Rife, B. D., Supuran, C. T. & McKenna, R. Structural study of interaction between brinzolamide and dorzolamide inhibition of human carbonic anhydrases. Bioorg Med Chem 21, 7210\u20137215 (2013).","journal-title":"Bioorg Med Chem"},{"key":"49094_CR53","doi-asserted-by":"publisher","first-page":"9435","DOI":"10.1021\/jm501003k","volume":"57","author":"V Dudutien\u0117","year":"2014","unstructured":"Dudutien\u0117, V. et al. Discovery and characterization of novel selective inhibitors of carbonic anhydrase IX. J. Med. Chem. 57, 9435\u20139446 (2014).","journal-title":"J. Med. Chem."},{"key":"49094_CR54","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S0021-9258(18)54025-4","volume":"268","author":"JF Krebs","year":"1993","unstructured":"Krebs, J. F. & Fierke, C. A. Determinants of catalytic activity and stability of carbonic anhydrase II as revealed by random mutagenesis. J. Biol. Chem. 268, 948\u2013954 (1993).","journal-title":"J. Biol. Chem."},{"key":"49094_CR55","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/j.1432-1033.1991.tb16054.x","volume":"198","author":"G Behravan","year":"1991","unstructured":"Behravan, G., Jonasson, P., Jonsson, B. H. & Lindskog, S. Structural and functional differences between carbonic anhydrase isoenzymes I and II as studied by site-directed mutagenesis. Eur. J. Biochem. 198, 589\u2013592 (1991).","journal-title":"Eur. J. Biochem."},{"key":"49094_CR56","doi-asserted-by":"publisher","first-page":"10609","DOI":"10.1073\/pnas.0904184106","volume":"106","author":"B Sj\u00f6blom","year":"2009","unstructured":"Sj\u00f6blom, B., Polentarutti, M. & Djinovic-Carugo, K. Structural study of X-ray induced activation of carbonic anhydrase. Proc. Natl. Acad. Sci. USA 106, 10609\u201310613 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"49094_CR57","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1021\/cr050262p","volume":"108","author":"VM Krishnamurthy","year":"2008","unstructured":"Krishnamurthy, V. M. et al. Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding. Chem. Rev. 108, 946\u20131051 (2008).","journal-title":"Chem. Rev."},{"key":"49094_CR58","doi-asserted-by":"crossref","unstructured":"Linkuvien\u0117, V. et al. Thermodynamic, kinetic, and structural parameterization of human carbonic anhydrase interactions toward enhanced inhibitor design. Quarterly Reviews of Biophysics 51 (2018).","DOI":"10.1017\/S0033583518000082"},{"key":"49094_CR59","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.str.2018.01.006","volume":"26","author":"A Kovalevsky","year":"2018","unstructured":"Kovalevsky, A. et al. \u2018To Be or Not to Be\u2019 Protonated: Atomic Details of Human Carbonic Anhydrase-Clinical Drug Complexes by Neutron Crystallography and Simulation. Structure 26, 383\u2013390.e3 (2018).","journal-title":"Structure"},{"issue":"2","key":"49094_CR60","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jsb.2018.12.009","volume":"205","author":"Katarina Koruza","year":"2019","unstructured":"Koruza, K. et al. Using neutron crystallography to elucidate the basis of selective inhibition of carbonic anhydrase by saccharin and a derivative. Journal of Structural Biology, https:\/\/doi.org\/10.1016\/j.jsb.2018.12.009 (2019).","journal-title":"Journal of Structural Biology"},{"key":"49094_CR61","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.bbrc.2012.02.038","volume":"419","author":"ES Pilka","year":"2012","unstructured":"Pilka, E. S., Kochan, G., Oppermann, U. & Yue, W. W. Crystal structure of the secretory isozyme of mammalian carbonic anhydrases CA VI: implications for biological assembly and inhibitor development. Biochem. Biophys. Res. Commun. 419, 485\u2013489 (2012).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"49094_CR62","doi-asserted-by":"publisher","first-page":"e4128","DOI":"10.7717\/peerj.4128","volume":"5","author":"MS Patrikainen","year":"2017","unstructured":"Patrikainen, M. S. et al. Identification and characterization of a novel zebrafish (Danio rerio) pentraxin-carbonic anhydrase. PeerJ 5, e4128 (2017).","journal-title":"PeerJ"},{"key":"49094_CR63","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ab.2016.10.005","volume":"515","author":"V Linkuvien\u0117","year":"2016","unstructured":"Linkuvien\u0117, V., Krainer, G., Chen, W.-Y. & Matulis, D. Isothermal titration calorimetry for drug design: Precision of the enthalpy and binding constant measurements and comparison of the instruments. Anal. Biochem. 515, 61\u201364 (2016).","journal-title":"Anal. Biochem."},{"issue":"2","key":"49094_CR64","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00249-018-1341-z","volume":"48","author":"Vaida Paketuryt\u0117","year":"2018","unstructured":"Paketuryt\u0117, V., Linkuvien\u0117, V., Krainer, G., Chen, W.-Y. & Matulis, D. Repeatability, precision, and accuracy of the enthalpies and Gibbs energies of a protein\u2013ligand binding reaction measured by isothermal titration calorimetry. European Biophysics Journal, https:\/\/doi.org\/10.1007\/s00249-018-1341-z (2018).","journal-title":"European Biophysics Journal"},{"key":"49094_CR65","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/cmdc.201402490","volume":"10","author":"V Dudutien\u0117","year":"2015","unstructured":"Dudutien\u0117, V. et al. Functionalization of fluorinated benzenesulfonamides and their inhibitory properties toward carbonic anhydrases. ChemMedChem 10, 662\u2013687 (2015).","journal-title":"ChemMedChem"},{"key":"49094_CR66","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3109\/14756366.2012.757223","volume":"29","author":"A Zubrien\u0117","year":"2014","unstructured":"Zubrien\u0117, A. et al. Benzenesulfonamides with benzimidazole moieties as inhibitors of carbonic anhydrases I, II, VII, XII and XIII. J Enzyme Inhib Med Chem 29, 124\u2013131 (2014).","journal-title":"J Enzyme Inhib Med Chem"},{"key":"49094_CR67","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1016\/j.bmc.2013.01.008","volume":"21","author":"V Dudutien\u0117","year":"2013","unstructured":"Dudutien\u0117, V. et al. 4-Substituted-2,3,5,6-tetrafluorobenzenesulfonamides as inhibitors of carbonic anhydrases I, II, VII, XII, and XIII. Bioorg. Med. Chem. 21, 2093\u20132106 (2013).","journal-title":"Bioorg. Med. Chem."},{"key":"49094_CR68","doi-asserted-by":"publisher","first-page":"6937","DOI":"10.1016\/j.bmc.2013.09.029","volume":"21","author":"E \u010capkauskait\u0117","year":"2013","unstructured":"\u010capkauskait\u0117, E. et al. Benzenesulfonamides with pyrimidine moiety as inhibitors of human carbonic anhydrases I, II, VI, VII, XII, and XIII. Bioorganic & Medicinal Chemistry 21, 6937\u20136947 (2013).","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"49094_CR69","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2013a visualization system for exploratory research and analysis. J Comput Chem 25, 1605\u20131612 (2004).","journal-title":"J Comput Chem"},{"key":"49094_CR70","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1093\/nar\/gkn072","volume":"36","author":"J Pei","year":"2008","unstructured":"Pei, J., Kim, B.-H. & Grishin, N. V. PROMALS3D: a tool for multiple protein sequence and structure alignments. Nucleic Acids Res 36, 2295\u20132300 (2008).","journal-title":"Nucleic Acids Res"},{"key":"49094_CR71","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/bioinformatics\/16.2.135","volume":"16","author":"E Beitz","year":"2000","unstructured":"Beitz, E. TeXshade: shading and labeling of multiple sequence alignments using LaTeX2e. Bioinformatics 16, 135\u2013139 (2000).","journal-title":"Bioinformatics"},{"key":"49094_CR72","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1529\/biophysj.108.134973","volume":"95","author":"P Cimmperman","year":"2008","unstructured":"Cimmperman, P. et al. A quantitative model of thermal stabilization and destabilization of proteins by ligands. Biophys. J. 95, 3222\u20133231 (2008).","journal-title":"Biophys. J."},{"key":"49094_CR73","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/978-1-61737-954-3_8","volume":"700","author":"PE Carrigan","year":"2011","unstructured":"Carrigan, P. E., Ballar, P. & Tuzmen, S. Site-directed mutagenesis. Methods Mol. Biol. 700, 107\u2013124 (2011).","journal-title":"Methods Mol. Biol."},{"key":"49094_CR74","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0005-2744(69)90420-3","volume":"185","author":"JF Morrison","year":"1969","unstructured":"Morrison, J. F. Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors. Biochim. Biophys. Acta 185, 269\u2013286 (1969).","journal-title":"Biochim. Biophys. Acta"},{"key":"49094_CR75","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/0076-6879(79)63019-7","volume":"63","author":"JW Williams","year":"1979","unstructured":"Williams, J. W. & Morrison, J. F. The kinetics of reversible tight-binding inhibition. Meth. Enzymol. 63, 437\u2013467 (1979).","journal-title":"Meth. Enzymol."},{"key":"49094_CR76","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3109\/14756360903571685","volume":"25","author":"L Baranauskien\u0117","year":"2010","unstructured":"Baranauskien\u0117, L. et al. Inhibition and binding studies of carbonic anhydrase isozymes I, II and IX with benzimidazo[1,2-c][1,2,3]thiadiazole-7-sulphonamides. J Enzyme Inhib Med Chem 25, 863\u2013870 (2010).","journal-title":"J Enzyme Inhib Med Chem"},{"key":"49094_CR77","doi-asserted-by":"publisher","first-page":"e36899","DOI":"10.1371\/journal.pone.0036899","volume":"7","author":"E Kazlauskas","year":"2012","unstructured":"Kazlauskas, E. et al. Thermodynamics of Aryl-Dihydroxyphenyl-Thiadiazole Binding to Human Hsp90. PLoS One 7, e36899 (2012).","journal-title":"PLoS One"},{"key":"49094_CR78","doi-asserted-by":"crossref","unstructured":"Goldberg, R. N., Kishore, N. & Lennen, R. M. Thermodynamic Quantities for the Ionization Reactions of Buffers. Journal of Physical and Chemical Reference Data 31 (2002).","DOI":"10.1063\/1.1416902"},{"key":"49094_CR79","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. XDS. Acta Cryst D 66, 125\u2013132 (2010).","journal-title":"Acta Cryst D"},{"key":"49094_CR80","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1107\/S0021889897006766","volume":"30","author":"A Vagin","year":"1997","unstructured":"Vagin, A. & Teplyakov, A. MOLREP: an Automated Program for Molecular Replacement. J Appl Cryst, J Appl Crystallogr 30, 1022\u20131025 (1997).","journal-title":"J Appl Cryst, J Appl Crystallogr"},{"key":"49094_CR81","first-page":"17","volume-title":"J Cheminform","author":"MD Hanwell","year":"2012","unstructured":"Hanwell, M. D. et al. Avogadro: An advanced semantic chemical editor, visualization, and analysis platform. J Cheminform 4, 17 (2012)."},{"key":"49094_CR82","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1107\/S0907444904023510","volume":"60","author":"AA Vagin","year":"2004","unstructured":"Vagin, A. A. et al. REFMAC5 dictionary: organization of prior chemical knowledge and guidelines for its use. Acta Crystallogr D Biol Crystallogr 60, 2184\u201395 (2004).","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"49094_CR83","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1107\/S0907444910045749","volume":"67","author":"MD Winn","year":"2011","unstructured":"Winn, M. D. et al. Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr 67, 235\u2013242 (2011).","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"49094_CR84","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"49094_CR85","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1107\/S0907444996012255","volume":"53","author":"GN Murshudov","year":"1997","unstructured":"Murshudov, G. N., Vagin, A. A. & Dodson, E. J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53, 240\u2013255 (1997).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"49094_CR86","doi-asserted-by":"publisher","first-page":"5360","DOI":"10.1002\/slct.201700531","volume":"2","author":"E \u010capkauskait\u0117","year":"2017","unstructured":"\u010capkauskait\u0117, E. et al. Combinatorial Design of Isoform-Selective N-Alkylated Benzimidazole-Based Inhibitors of Carbonic Anhydrases. ChemistrySelect 2, 5360\u20135371 (2017).","journal-title":"ChemistrySelect"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49094-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49094-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49094-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T08:06:24Z","timestamp":1671264384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49094-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,3]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["49094"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-49094-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,3]]},"assertion":[{"value":"17 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.M. declares that he has patents and patent applications pending on CA inhibitors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12710"}}